Retained Earnings (Accumulated Deficit) of Regencell Bioscience Holdings Ltd from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Regencell Bioscience Holdings Ltd quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
  • Regencell Bioscience Holdings Ltd Retained Earnings (Accumulated Deficit) for the quarter ending 30 Jun 2025 was $25,201,116, a 17% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Regencell Bioscience Holdings Ltd Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $25,201,116 -$3,584,213 -17% 30 Jun 2025 20-F 31 Oct 2025 2025 FY
Q2 2024 $21,616,903 -$4,301,837 -25% 30 Jun 2024 20-F 31 Oct 2025 2025 FY
Q2 2023 $17,315,066 -$5,871,130 -51% 30 Jun 2023 20-F 25 Oct 2024 2024 FY
Q2 2022 $11,443,936 -$7,445,943 -186% 30 Jun 2022 20-F 27 Oct 2023 2023 FY
Q2 2021 $3,997,993 -$1,346,745 -51% 30 Jun 2021 20-F 31 Oct 2022 2022 FY
Q2 2020 $2,651,248 30 Jun 2020 20-F 29 Oct 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.